Immune reconstitution disease associated with parasitic infections following antiretroviral treatment
- PMID: 17042934
- PMCID: PMC1636681
- DOI: 10.1111/j.1365-3024.2006.00900.x
Immune reconstitution disease associated with parasitic infections following antiretroviral treatment
Abstract
HIV-associated immune reconstitution disease (IRD) is the clinical presentation or deterioration of opportunistic infections that results from enhancement of pathogen-specific immune responses among patients responding to antiretroviral treatment (ART). The vast majority of reported cases of IRD have been associated with mycobacterial, chronic viral and invasive fungal infections; such cases result from dysregulated augmentation of cell-mediated type 1 cytokine-secreting host immune responses. However, the spectrum of infections now recognized as associated with IRD is expanding and includes a number of parasitic infections, which may be mediated by different immunopathological mechanisms. These include leishmaniasis (visceral, cutaneous, mucosal and post kala azar dermal leishmaniasis), schistosomiasis and strongyloidiasis. Since the major burden of HIV lies in resource-limited countries where access to ART is now rapidly expanding, increased awareness and knowledge of these phenomena is important. Here we review the clinical spectrum and pathogenesis of IRD associated with parasitic infections.
Similar articles
-
Immune reconstitution disease associated with parasitic infections following initiation of antiretroviral therapy.Curr Opin Infect Dis. 2007 Oct;20(5):482-8. doi: 10.1097/QCO.0b013e3282a6463d. Curr Opin Infect Dis. 2007. PMID: 17762781 Review.
-
Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals.Lancet Infect Dis. 2005 Jun;5(6):361-73. doi: 10.1016/S1473-3099(05)70140-7. Lancet Infect Dis. 2005. PMID: 15919622 Review.
-
Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy.J HIV Ther. 2002 May;7(2):46-51. J HIV Ther. 2002. PMID: 12553688 Review.
-
Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy.J Clin Virol. 2001 Oct;22(3):279-87. doi: 10.1016/s1386-6532(01)00200-1. J Clin Virol. 2001. PMID: 11564593
-
Post-kala-azar dermal Leishmaniasis in two different clinical contexts.An Bras Dermatol. 2015 May-Jun;90(3 Suppl 1):108-10. doi: 10.1590/abd1806-4841.20153373. An Bras Dermatol. 2015. PMID: 26312689 Free PMC article.
Cited by
-
Leprosy after starting antiretroviral treatment.BMJ. 2007 Feb 3;334(7587):217-8. doi: 10.1136/bmj.39107.480359.80. BMJ. 2007. PMID: 17272530 Free PMC article.
-
High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States.PLoS Negl Trop Dis. 2011 Apr 12;5(4):e1034. doi: 10.1371/journal.pntd.0001034. PLoS Negl Trop Dis. 2011. PMID: 21532747 Free PMC article.
-
Leishmaniasis as a Manifestation of Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV-Infected Patients: A Literature Review.J Int Assoc Provid AIDS Care. 2015 Sep-Oct;14(5):402-7. doi: 10.1177/2325957414555225. Epub 2014 Oct 20. J Int Assoc Provid AIDS Care. 2015. PMID: 25331225 Free PMC article.
-
Strongyloidosis Hyperinfection Syndrome in an HIV-Infected Patient: A Rare Manifestation of Immune Reconstitution Inflammatory Syndrome.Case Rep Infect Dis. 2018 Oct 28;2018:6870768. doi: 10.1155/2018/6870768. eCollection 2018. Case Rep Infect Dis. 2018. PMID: 30510823 Free PMC article.
-
Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy.J Neurovirol. 2008 Nov;14(6):569-73. doi: 10.1080/13550280802304753. J Neurovirol. 2008. PMID: 19021074
References
-
- Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119–129. - PubMed
-
- Palella FJ, Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860. - PubMed
-
- Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998;352:1725–1730. - PubMed
-
- Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 1997;277:112–116. - PubMed
-
- Carcelain G, Debre P, Autran B. Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy. Curr Opin Immunol. 2001;13:483–488. - PubMed